GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen Post author:Sam Post published:November 21, 2017 Post category:BioPharma HIV patients have a new maintenance drug in their arsenal of medication. Source: BioSpace You Might Also Like Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? May 4, 2017 Show Me The Money: Bay Area???s Top 5 Venture Capital-Backed Biotechs September 14, 2017 Natus Medical Pays $48 Million for Integra LifeSciences' Neurosurgery Assets September 11, 2017
